The report said the technology has helped reduce clinician burnout while improving documentation quality and the patient experience.
Also, South Korean medical AI companies JLK and Coreline Soft announced recent regulatory approvals in Japan and the United States.
The partnership will give customers easy access to GLP-1 class drugs and other anti-obesity medications.
Culina Health announces its first C-suite hire since its inception.
The company, spun out of MIT and backed by Define Ventures, GV and Flare Capital Partners, was founded by veteran AI and clinical leaders from MIT, Harvard, Microsoft and Google.
The collaboration aims to integrate Lamar Health's specialty medication-focused AI platform into Uptiv Health's operations.
The companies said the aim of the partnership is to address the pressure pathologists face due to the global shortage of pathologists and the increasing number of cancer patients.
The company's SimpleSense wearable will ingest glucose data from the Dexcom G7 continuous glucose monitor system.
The company says it partnered with child psychologists to develop an online safety platform for individuals and families to protect children from "technology's negative effects."
The company will use the funds to invest in technology and expand into new market segments.
